C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/54 (2006.01) C12N 5/10 (2006.01) C12N 9/12 (2006.01) C12N 15/70 (2006.01) C12Q 1/34 (2006.01) C12Q 1/48 (2006.01)
Patent
CA 2325228
The present invention relates to the identification, isolation and purification of the catalytic domain of the human effector checkpoint protein kinase (hChkl). A 1.7.OMICRON. crystal structure of the hChkl kinase domain in the active conformation is reported herein. The kinase domain of hChkl and its associated crystal structure is described for use in the discovery, identification and characterization of inhibitors of hChkl. This structure provides a three- dimensional description of the binding site of the hChkl for structure-based design of small molecule inhibitors thereof as therapeutic agents. Inhibitors of hChkl find utility in the treatment of hyperproliferative disorders such as HIV and cancer.
Anderson Mark Brian
Chen Ping
Deng Ya-Li
Gaur Smita
Kan Chen-Chen
Agouron Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Catalytic domain of the human effector cell cycle checkpoint... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Catalytic domain of the human effector cell cycle checkpoint..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catalytic domain of the human effector cell cycle checkpoint... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1406109